ClinicalTrials.govpublic full text
Dose Escalation, Expansion Study of Vofatamab (B-701) in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma
locally advanced or metastatic urothelial cell carcinoma, urinary bladder disease, urological diseases, urothelial cell carcinoma, ucc, bladder cancer, vofatamab, fgfr3, invasive bladder cancer, targeted therapy, transitional cell carcinoma, tcc
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 911515
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.